Select Medical Holdings CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Select Medical Holdings Corporation reported a significant increase in income from continuing operations for 2025, alongside strategic executive promotions and ongoing evaluation of a take-private proposal.
NYSE
Select Medical Holdings Corporation announces its 2024 financial results, including a revenue of $5.2 billion and the completion of the spin-off of Concentra.
NYSE
Select Medical Holdings Corporation files its 10-K report for the year ended December 31, 2023, detailing financial performance and announcing the planned separation of its Concentra business.